EBSCO
SPONSORED
Health systems are seeking to provide relevant, evidence-based content that will lead to more effective shared decision-making conversations, says Christian Patrick, VP of clinical decisions at EBSCO.
Also: 23andMe gets FDA nod for direct-to-consumer test for hereditary colorectal cancer syndrome; Mobile Heartbeat announces integration with Imprivata.